Metraipolis › archive › dc_3571e2d62966
Dual PI3K and HDAC inhibitor, CUDC-907, effectively inhibits endometrial cancer growth in vitro and in vivo — Europe PMC PMID:41262902
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41262902
- DOI
- 10.3389/fonc.2025.1531805
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T19:14:55.903Z
- SHA-256 of the archived text
ebfebd61438dabe6e6e7b7f97609c2595d1d47ff40c10578b51640de63ba79bb- Stable URL of this page
https://metraipolis.com/documento/dc_3571e2d62966
How to cite
Dual PI3K and HDAC inhibitor, CUDC-907, effectively inhibits endometrial cancer growth in vitro and in vivo — Europe PMC PMID:41262902 — Europe PMC (en), https://europepmc.org/article/MED/41262902 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3571e2d62966 (Metraipolis archive dc_3571e2d62966, sha256 ebfebd61438dabe6e6e7b7f97609c2595d1d47ff40c10578b51640de63ba79bb)
BibTeX
@misc{dc3571e2d62966,
title = {Dual PI3K and HDAC inhibitor, CUDC-907, effectively inhibits endometrial cancer growth in vitro and in vivo — Europe PMC PMID:41262902},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41262902},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3571e2d62966; sha256 ebfebd61438dabe6e6e7b7f97609c2595d1d47ff40c10578b51640de63ba79bb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41262902. Agents can read the archived copy with the MCP tool read_document.